Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2011,NCI,5R01CA077429-12,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$419,987"
Ovarian Cancer,2011,NCI,5R01CA131407-04,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$335,421"
Ovarian Cancer,2011,NCI,5R01CA104996-07,,Promoting Tumor Immunity by Cross-linking B7-DC,"PEASE, LARRY",MAYO CLINIC,MN,"$239,311"
Ovarian Cancer,2011,NCI,5R01CA119200-05,,Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model,"BARTON, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$274,008"
Ovarian Cancer,2011,NCI,5R01CA103937-07,,Molecular Diagnostics for Malignant Effusion,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$328,003"
Ovarian Cancer,2011,NCI,5R01CA123233-04,,Regulation of JNK-signaling molecules by the gep oncogenes,"DHANASEKARAN, DANNY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,$1
Ovarian Cancer,2011,NCI,5R01CA124630-05,,PTTG Role in Ovarian Tumorigenesis and Matastasis,"KAKAR, SHAM",UNIVERSITY OF LOUISVILLE,KY,"$245,488"
Ovarian Cancer,2011,NCI,5R01CA142838-02,,Role of redox state in ovarian cancer response to cisplatin,"DANIEL, LARRY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$292,962"
Ovarian Cancer,2011,NCI,5R01CA047135-22,,Discovery of novel cytotoxic natural products from marine sponges and fungi,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$462,978"
Ovarian Cancer,2011,NCI,5R01CA144057-07,,Evaluation of Vectors based on group B adenoviruses,"LIEBER, ANDRE",UNIVERSITY OF WASHINGTON,WA,"$320,779"
Ovarian Cancer,2011,NCI,5R01CA114340-05,,Antiangiogenic Gene Therapy of Ovarian and Breast Cancers,"RAMAKRISHNAN, SUNDARAM",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$245,614"
Ovarian Cancer,2011,NCI,5R01CA124951-02,,Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy,"FANG, BINGLIANG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$309,964"
Ovarian Cancer,2011,NCI,5R01CA129080-04,,The Roles of HBXAP Gene in Ovarian Cancer,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$330,091"
Ovarian Cancer,2011,NCI,5R21CA143736-02,,Development of a multimarker urine-based test for early diagnosis and screening o,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$191,776"
Ovarian Cancer,2011,NCI,5R01CA142776-02,,"The role of microRNA, mir-30d, in the initiation and progression of cancer","ZHANG, LIN",UNIVERSITY OF PENNSYLVANIA,PA,"$322,040"
Ovarian Cancer,2011,NCI,5R01CA095175-08,,Analysis of BRCA1 recombination functions,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$295,223"
Ovarian Cancer,2011,NCI,5R01CA123249-04,,Regulation of Serine Protease HtrA1 and Chemoresponse,"SHRIDHAR, VIJI",MAYO CLINIC,MN,"$304,127"
Ovarian Cancer,2011,NCI,5R01CA102707-07,,Inhibition  of Cytochrome c-induced Caspase Activation,"KORNBLUTH, SALLY",DUKE UNIVERSITY,NC,"$263,055"
Ovarian Cancer,2011,NCI,5R01CA133057-03,,Prognostic markers for ovarian cancer,"MOK, SAMUEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$287,595"
Ovarian Cancer,2011,NCI,5R01CA132091-04,,Targeted Nanoparticle DNA Therapy for Ovarian Cancer,"SAWICKI, JANET",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$266,946"
Ovarian Cancer,2011,NCI,5R01CA123197-05,,Death Receptor-mediated Apoptosis and Therapy Strategies in Ovarian Cancer,"ZHOU, TONG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$444,659"
Ovarian Cancer,2011,NIEHS,5R01ES005775-19,,"Hypoxia, Genetic Instability and DNA Mismatch Repair","GLAZER, PETER",YALE UNIVERSITY,CT,"$364,578"
Ovarian Cancer,2011,NCI,5R01CA101850-07,,ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING,"BAE, YOU",UNIVERSITY OF UTAH,UT,"$263,045"
Ovarian Cancer,2011,NCI,5R01CA109298-07,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$338,690"
Ovarian Cancer,2011,NIGMS,5R01GM052418-12,,Mass Spectrometry Studies on Radical Reactions of DNA,"KENTTAMAA, HILKKA",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$210,739"
Ovarian Cancer,2011,NCI,5R01CA133117-03,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$326,066"
Ovarian Cancer,2011,NCI,1R01CA155025-01,,The role of a novel BRCA1 associated complex in DNA damage response and tumor sup,"WANG, BIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,850"
Ovarian Cancer,2011,NCI,5R01CA114343-05,,Haplotype-Based Genome Screen for Ovarian Cancer Loci,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$1,078,602"
Ovarian Cancer,2011,NCI,5R01CA141078-02,,Multifunctional roles of homeobox gene DLX4 in ovarian cancer,"NAORA, HONAMI",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2011,NCI,5R01CA108970-07,,CD4+ Memory T-Cells in Human Tumor Microenvironment,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$296,719"
Ovarian Cancer,2011,NIDCR,1R03DE021438-01,,Genetic Markers Associated with Epithelial Ovarian Cancer and Hypodontia,"MORFORD, LORRI",UNIVERSITY OF KENTUCKY,KY,"$111,375"
Ovarian Cancer,2011,NCI,1R21CA155424-01,,Enzyme-delivery scaffold technology for targeted cancer killing.,"LAVIE, ARNON",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$231,069"
Ovarian Cancer,2011,NCI,5R01CA120659-04,,"Role of a novel angiogenic factor, YKL-40, in breast cancer progression","SHAO, RONG",UNIVERSITY OF MASSACHUSETTS AMHERST,MA,"$218,062"
Ovarian Cancer,2011,NCI,1R21CA155479-01,,Use of nanogels to target delivery of siRNA to cancer cells in mice,"MCDONALD, JOHN",GEORGIA INSTITUTE OF TECHNOLOGY,GA,"$240,470"
Ovarian Cancer,2011,NCI,5R01CA149356-11,,The Role of MicroRNAs in Tumor Progression,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$283,051"
Ovarian Cancer,2011,NCI,5R03CA139905-02,,Sociocultural Factors and BRCA Genetic Counseling for Diverse Latinas,"SUSSNER, KATARINA",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$82,208"
Ovarian Cancer,2011,NCI,5R01CA116167-05,,BRCA2 missense mutations and breast cancer,"COUCH, FERGUS",MAYO CLINIC,MN,"$512,304"
Ovarian Cancer,2011,NCI,5R03CA150039-02,,MITOCHONDRIAL GENOME ANALYSIS OF EPITHELIAL SEROUS OVARIAN CARCINOMA,"AIKHIONBARE, FELIX",MOREHOUSE SCHOOL OF MEDICINE,GA,"$70,000"
Ovarian Cancer,2011,NCI,5R21CA137681-02,,A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers,"CHILES, THOMAS",BOSTON COLLEGE,MA,"$211,697"
Ovarian Cancer,2011,NCI,5R01CA131200-03,,Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases,"EBLEN, SCOTT",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$296,116"
Ovarian Cancer,2011,NIGMS,5SC1GM082340-02,,The Fulvene Approach to the Syntheses of Antitumor Agents,"ERDEN, IHSAN",SAN FRANCISCO STATE UNIVERSITY,CA,"$265,939"
Ovarian Cancer,2011,NCI,5R01CA123219-04,,The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$305,140"
Ovarian Cancer,2011,NCI,7R01CA136549-03,,Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,"LU, XIONGBIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2011,NCI,5R03CA150136-02,,Validating Cancer Risk Models: a Pilot Study to Evaluate Cost-efficient Methods,"WHITTEMORE, ALICE",STANFORD UNIVERSITY,CA,"$80,078"
Ovarian Cancer,2011,NCI,2R01CA079716-12A1,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$326,412"
Ovarian Cancer,2011,NICHD,5R01HD057110-04,,Molecular Pathways Controlling Ovarian Gene Expression,"STOCCO, CARLOS",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$288,726"
Ovarian Cancer,2011,NCI,7R01CA140323-02,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$366,458"
Ovarian Cancer,2011,NCI,1R03CA143918-01A1,,Characteristics of tubal ligation and risk of epithelial ovarian cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$101,020"
Ovarian Cancer,2011,NCI,5R01CA134424-03,,A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc,"KOSTUK, RAYMOND",UNIVERSITY OF ARIZONA,AZ,"$429,845"
Ovarian Cancer,2011,NCI,5R21CA150237-02,,Targeting lipid metabolic and signaling enzyme in ovarian cancer,"NG, SHU-WING",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$230,673"
Ovarian Cancer,2011,NCI,5R01CA142832-02,,Novel Biomarkers in Ovarian Cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$347,562"
Ovarian Cancer,2011,NCI,5R01CA149429-02,,The Mitochondrial Genome and Ovarian Cancer Risk,"PHELAN, CATHERINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$624,525"
Ovarian Cancer,2011,NCI,5R01CA099985-05,,Human Tregs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$216,969"
Ovarian Cancer,2011,NCI,5R01CA139159-03,,Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer A,"STIERLE, ANDREA",UNIVERSITY OF MONTANA,MT,"$209,710"
Ovarian Cancer,2011,NCI,5R01CA136596-03,,"The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis","CONNOLLY, DENISE",FOX CHASE CANCER CENTER,PA,"$316,103"
Ovarian Cancer,2011,NCI,5R01CA138762-03,,Splicing factors as therapeutic targets for the treatment of ovarian cancer,"BECK, WILLIAM",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$303,952"
Ovarian Cancer,2011,NCI,5R01CA131183-04,,"RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression","LIU, JINSONG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$247,971"
Ovarian Cancer,2011,NCI,5R01CA116984-06,,G Proteins and Their Receptors in Tumor Cell Metastasis,"DHANASEKARAN, DANNY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$289,351"
Ovarian Cancer,2011,NCI,5R01CA123088-05,,Novel immunosupressive macrophages in human ovarian tumor,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$280,136"
Ovarian Cancer,2011,NCI,5R01CA136494-03,,Molecular mechanism of antiangiogenic properties of gold nanoparticle,"MUKHERJEE, PRIYABRATA",MAYO CLINIC,MN,"$273,714"
Ovarian Cancer,2011,NCI,5R01CA136547-03,,Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer,"PENG, KAH-WHYE",MAYO CLINIC,MN,"$424,154"
Ovarian Cancer,2011,NCI,1R21CA156944-01,,Biophotonics Noninvasive Detection of Ovarian Cancer,"BACKMAN, VADIM",NORTHWESTERN UNIVERSITY,IL,"$329,563"
Ovarian Cancer,2011,NCI,1R01CA157176-01,,"Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer","BICKELL, NINA",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$528,302"
Ovarian Cancer,2011,NCI,5R01CA136491-03,,Development of an Assay for the Early Detection of Ovarian Cancer,"MOORE, RICHARD",WOMEN AND INFANTS HOSPITAL-RHODE ISLAND,RI,"$414,995"
Ovarian Cancer,2011,NCI,5R01CA135006-03,,Role of TbRIII in Regulating Motility and Invasion,"BLOBE, GERARD",DUKE UNIVERSITY,NC,"$425,769"
Ovarian Cancer,2011,NCI,5R01CA137041-03,,MicroRNAs in Human Ovarian Cancer,"CHENG, JIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$336,129"
Ovarian Cancer,2011,NCI,5R01CA086984-12,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$292,490"
Ovarian Cancer,2011,NCI,5K08CA148887-02,,Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer,"KHABELE, DINEO",VANDERBILT UNIVERSITY,TN,"$159,084"
Ovarian Cancer,2011,NCI,5R01CA138556-03,,Impact of exercise on ovarian cancer prognosis,"IRWIN, MELINDA",YALE UNIVERSITY,CT,"$631,739"
Ovarian Cancer,2011,NCI,5R01CA039742-27,,Epidemiology of Cancer in a Cohort of Older Women,"ROBIEN, KIMBERLY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$444,188"
Ovarian Cancer,2011,NCI,5R01CA122728-04,,Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$329,744"
Ovarian Cancer,2011,NCI,5R01CA131965-03,,Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium,"SWISHER, ELIZABETH",UNIVERSITY OF WASHINGTON,WA,"$313,989"
Ovarian Cancer,2011,NCI,5R01CA127913-04,,MyD88-bearing tumors in immune-regulation and chemo-resistance,"MOR, GIL",YALE UNIVERSITY,CT,"$333,111"
Ovarian Cancer,2011,NCI,5R01CA124515-06,,Vascular Leukocytes influence the tumor microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$312,204"
Ovarian Cancer,2011,NCI,5R01CA121187-06,,Monitoring of advanced virotherapy for ovarian cancer,"CURIEL, DAVID",WASHINGTON UNIVERSITY,MO,"$280,136"
Ovarian Cancer,2011,NCI,1R33CA147988-01A1,,Development and Application of Novel Glycan-Specific Reagents to Facilitate Early,"MUDDIMAN, DAVID",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$330,496"
Ovarian Cancer,2011,NCI,5R01CA132755-04,,MOLECULAR MECHANISMS OF BRCA1-DEPENDENT DNA DAMAGE RESPONSE AND TUMORIGENESIS,"YU, XIAOCHUN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$305,938"
Ovarian Cancer,2011,NCI,5R01CA094172-10,,Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas,"CHO, KATHLEEN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$253,343"
Ovarian Cancer,2011,NCI,5R01CA135179-03,,INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$382,346"
Ovarian Cancer,2011,NCI,5R01CA114037-05,,Taxane Resistance in Breast and Ovarian Cancer Cells,"SIKIC, BRANIMIR",STANFORD UNIVERSITY,CA,"$288,798"
Ovarian Cancer,2011,NCI,5R01CA130911-04,,Chimeric NKG2D receptors in ovarian cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$321,839"
Ovarian Cancer,2011,NCI,5R01CA126841-03,,Regulatory T Cell Function in Ovarian Cancer,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$626,563"
Ovarian Cancer,2011,OD,5R01CA126841-03,,Regulatory T Cell Function in Ovarian Cancer,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$15,000"
Ovarian Cancer,2011,NCI,5K07CA143047-02,,Genetic Epidemiology of Ovarian and Prostate Cancer,"SIEH, WEIVA",STANFORD UNIVERSITY,CA,"$173,448"
Ovarian Cancer,2011,NCI,5R01CA125636-05,,The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$310,947"
Ovarian Cancer,2011,NCI,5R01CA135312-04,,Dendritic nanomedicine for cancer imaging and treatment,"TUNG, CHING-HSUAN",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$301,913"
Ovarian Cancer,2011,NCI,5R01CA142081-02,,Epidemiology of Ovarian Cancer in African-American Women,"SCHILDKRAUT, JOELLEN",DUKE UNIVERSITY,NC,"$2,239,114"
Ovarian Cancer,2011,NCI,5R21CA137686-03,,High-throughput intracellular microrheology: a new tool for cancer research,"WIRTZ, DENIS",JOHNS HOPKINS UNIVERSITY,MD,"$201,131"
Ovarian Cancer,2011,NCI,5R01CA136512-03,,BRCA1 Function in Post-Damage Nuclear Foci,"LIVINGSTON, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$511,671"
Ovarian Cancer,2011,NCI,5R01CA124545-04,,TRAIL Receptor Signaling in Human Tumors,"THORBURN, ANDREW",UNIVERSITY OF COLORADO DENVER,CO,"$412,266"
Ovarian Cancer,2011,NCI,5R01CA058598-13,,Collaborative Genetic Study of Ovarian Cancer Risk,"GOODMAN, MARC",UNIVERSITY OF HAWAII AT MANOA,HI,"$482,794"
Ovarian Cancer,2011,NCI,5R01CA140933-03,,Biobehavioral Influences and the Ovarian Tumor Microenvironment,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$534,427"
Ovarian Cancer,2011,NCI,5R01CA115780-06,,Diagnosis of Ovarian Cancer by Confocal Microendoscopy,"GMITRO, ARTHUR",UNIVERSITY OF ARIZONA,AZ,"$277,038"
Ovarian Cancer,2011,NCI,5R01CA131400-03,,VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER,"SPRINGETT, GREGORY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$336,129"
Ovarian Cancer,2011,NCI,5R01CA099471-07,,Gonadotropins & Cox-2 in Ovarian Cancer Prevention,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$375,772"
Ovarian Cancer,2011,NCI,5R01CA120429-05,,Regulation of MDR1 Expression and Drug Resistance by CD44,"RODRIGUEZ-RODRIGUEZ, LORNA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$287,508"
Ovarian Cancer,2011,NCI,1R01CA157664-01,,Initiation and evolution of the ovarian cancer microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$363,981"
Ovarian Cancer,2011,NCI,5R01CA031841-31,,Synthetic Studies on Tumor Promoters and Inhibitors,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$329,840"
Ovarian Cancer,2011,NIGMS,1R01GM097495-01,,"Cross-talk between PKA, cellular tension, and Ca2+ channels during cell migration","HOWE, ALAN",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$282,913"
Ovarian Cancer,2011,NIGMS,5R01GM088055-12,,Structural and Functional Characterization of BRCA1/BARD1,"KLEVIT, RACHEL",UNIVERSITY OF WASHINGTON,WA,"$370,628"
Ovarian Cancer,2011,NCI,5R01CA142783-02,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$309,964"
Ovarian Cancer,2011,NCI,1R01CA158881-01,,Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$568,797"
Ovarian Cancer,2011,NINR,5R01NR010735-04,,Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed,"DONOVAN, HEIDI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$555,577"
Ovarian Cancer,2011,NCI,5R01CA138628-02,,Role of the BMP SMADs in Oncogenesis,"PANGAS, STEPHANIE",BAYLOR COLLEGE OF MEDICINE,TX,"$354,370"
Ovarian Cancer,2011,NCI,5R01CA115483-07,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$299,038"
Ovarian Cancer,2011,NCI,5U10CA027469-31,,Gynecologic Oncology Group,"DISAIA, PHILIP",GYNECOLOGIC ONCOLOGY GROUP,MD,"$9,434,066"
Ovarian Cancer,2011,NCI,5R01CA148747-02,,Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer,"CLIBY, WILLIAM",MAYO CLINIC,MN,"$317,411"
Ovarian Cancer,2011,NCI,5R21CA137684-02,,Novel targeted therapies for BRCA-associated cancer,"WEITZEL, JEFFREY",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$334,117"
Ovarian Cancer,2011,NCI,5R01CA138533-02,,Multifunctional Nanotherapeutics for Cancer Treatment and Imaging,"MINKO, TAMARA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$307,721"
Ovarian Cancer,2011,NCI,5R33CA110499-05,,Molecular Profiling to Predict Response to Chemotherapy,"LANCASTER, JOHNATHAN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$266,563"
Ovarian Cancer,2011,NCI,2R15CA125731-02A1,,Functional Outcomes of Cdk6 and Eya2 Interaction,"GROSSEL, MARTHA",CONNECTICUT COLLEGE,CT,"$419,375"
Ovarian Cancer,2011,RMAP,1R21NS074091-01,,High-throughput imaging of Hedgehog pathway components at the primary cilium,"ROHATGI, RAJAT",STANFORD UNIVERSITY,CA,"$158,000"
Ovarian Cancer,2011,NCI,5U01CA128535-05,,Early Cancer Detection & Prognosis through Glycomics,"NOVOTNY, MILOS",INDIANA UNIVERSITY BLOOMINGTON,IN,"$361,949"
Ovarian Cancer,2011,NCI,5R37CA070867-14,,Cancer Risk Reduction and Diet: A Cohort Study of Women,"ZHENG, WEI",VANDERBILT UNIVERSITY,TN,"$945,286"
Ovarian Cancer,2011,NCI,1R01CA148826-01A1,,Characterizing Notch3 Signaling in Ovarian Cancer,"WANG, TIAN-LI",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Ovarian Cancer,2011,NCI,2R01CA109545-05A1,,Receptor Cross-Talk in Early Metastatic Dissemination,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$296,819"
Ovarian Cancer,2011,NCI,1R03CA159080-01,,Mammographic Breast Density and Ovarian Cancer,"WERNLI, KAREN",GROUP HEALTH COOPERATIVE,WA,"$80,000"
Ovarian Cancer,2011,NCI,5R43CA154339-02,,Magnetic Nanoparticles and Quantum Dots for Diagnosis of Early Stage Ovarian Canc,"AGUILAR, ZORAIDA","OCEAN NANOTECH, LLC",AR,"$141,192"
Ovarian Cancer,2011,NCI,5K25CA120350-05,,A near-infrared contrast agent for targeted imaging of cancer,"ROMANOWSKI, MAREK",UNIVERSITY OF ARIZONA,AZ,"$145,343"
Ovarian Cancer,2011,NCI,5R01CA085289-08,,DNA Methylation and Ovarian Cancer,"NEPHEW, KENNETH",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$234,310"
Ovarian Cancer,2011,NIGMS,5U01GM097119-02,,NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN),"MARDIS, ELAINE",WASHINGTON UNIVERSITY,MO,"$577,848"
Ovarian Cancer,2011,NCI,1K08CA151892-01A1,,Targeting Src Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer,"SIMPKINS, FIONA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$161,408"
Ovarian Cancer,2011,NCI,5R01CA125231-05,,A Multi-State Study of Cancer Treatment and Outcomes Among American Indians,"RAMSEY, SCOTT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$284,400"
Ovarian Cancer,2011,NCI,5R01CA132630-05,,Chemical Probes for Metabolic Pathway Discovery in Human Disease,"CRAVATT, BENJAMIN",SCRIPPS RESEARCH INSTITUTE,CA,"$425,482"
Ovarian Cancer,2011,NCI,5R01CA141154-02,,Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data,"PEARCE, CELESTE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$631,470"
Ovarian Cancer,2011,NINR,5F31NR012341-02,,"Prophylactic, risk-reducing surgery in BRCA-positive women:  sexual functioning a","TOLLIN, SHARON",UNIVERSITY OF SOUTH FLORIDA,FL,"$30,566"
Ovarian Cancer,2011,NIBIB,5R01EB011523-02,,Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu,"CHOI, HAK SOO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$489,293"
Ovarian Cancer,2011,NCI,5R01CA127239-04,,pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics,"NATARAJAN, AMARNATH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$270,598"
Ovarian Cancer,2011,NCI,5R01CA118678-05,,Apoptotic regulators in ovarian cancer,"MOR, GIL",YALE UNIVERSITY,CT,"$305,017"
Ovarian Cancer,2011,NCI,5K07CA131094-04,,Epigentics and Female Reproductive Cancers,"PERRIN, MARY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$139,320"
Ovarian Cancer,2011,NCI,5R01CA092889-10,,Role of TGFbeta in Microtubule Dynamics,"MULDER, KATHLEEN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$259,680"
Ovarian Cancer,2011,NCI,5K25CA128666-05,,Comparative Proteomics Applied to the Avian Model of Ovarian Cancer,"HAWKRIDGE, ADAM",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$143,370"
Ovarian Cancer,2011,NCI,5F32CA142117-03,,Modulation of tumor-associated macrophage phenotype by S1P receptors,"BLAHO, VICTORIA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$54,734"
Ovarian Cancer,2011,NCI,5R01CA094069-10,,"""Statistical Methods for Genetic Epidemiology""","WHITTEMORE, ALICE",STANFORD UNIVERSITY,CA,"$558,584"
Ovarian Cancer,2011,NCI,1R43CA159478-01,,Utrasensitive bioassays using palladium catalyzed chemical amplification,"LELENTAL, MARK","BIOFORMATIX, INC.",CA,"$199,996"
Ovarian Cancer,2011,NCI,1F32CA159523-01,,Understanding the origin and pathogenesis of epithelial ovarian cancer,"KIM, JAEYEON",BAYLOR COLLEGE OF MEDICINE,TX,"$53,042"
Ovarian Cancer,2011,NCI,5R01CA095319-09,,Novel Fas/CD95 Signaling Mechanisms,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$264,833"
Ovarian Cancer,2011,NCI,5R21CA143616-02,,Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125),"PATANKAR, MANISH",UNIVERSITY OF WISCONSIN MADISON,WI,"$156,650"
Ovarian Cancer,2011,NCI,1F32CA159558-01,,Role of p190RhoGEF (Rgnef) in cell motility and tumor progression,"MILLER, NICHOL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$53,042"
Ovarian Cancer,2011,NCI,1R41CA156933-01A1,,Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer,"KOPECEK, JINDRICH",THERATARGET,UT,"$148,304"
Ovarian Cancer,2011,NCI,5R01CA134487-04,,Mesothelin as biomarker and therapeutic target,"HELLSTROM, INGEGERD",UNIVERSITY OF WASHINGTON,WA,"$261,900"
Ovarian Cancer,2011,NCI,1F31CA159804-01,,Integrin Linked Kinase and Ovarian Cancer Metastasis,"BRUNEY, LANA",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$28,258"
Ovarian Cancer,2011,NCI,5F31CA144083-03,,Defining double-stranded RNA receptor induced apoptosis in ovarian cancer.,"SCHRAMM, DANIELLE",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$32,890"
Ovarian Cancer,2011,NCI,5K05CA136967-03,,Research and Mentoring on Energetic Factors and Cancer: Established Investigator,"BERNSTEIN, LESLIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$139,569"
Ovarian Cancer,2011,NIAID,5SC1AI089073-03,,Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,"SON, DEOK-SOO",MEHARRY MEDICAL COLLEGE,TN,"$358,962"
Ovarian Cancer,2011,NCI,5R01CA129142-03,,Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women,"KINNEY, ANITA",UNIVERSITY OF UTAH,UT,"$571,413"
Ovarian Cancer,2011,NCI,5U01CA152637-02,,Breast and Ovary Cancer Clinical Validation Center,"LI, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$794,647"
Ovarian Cancer,2011,NIAID,5K06AI004739-50,,BIOCHEMISTRY OF VIRAL REPLICATION,"GREEN, MAURICE",SAINT LOUIS UNIVERSITY,MO,"$33,939"
Ovarian Cancer,2011,NCI,5R01CA108990-07,,Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$565,354"
Ovarian Cancer,2011,NCI,1R03CA153815-01A1,,The High Cost of Risk Reduction: Addressing Sexual Dysfunction after Oophorectomy,"BOBER, SHARON",DANA-FARBER CANCER INSTITUTE,MA,"$87,500"
Ovarian Cancer,2011,NCI,5U01CA152755-02,,An integrated systems biology approach for ovarian cancer biomarker discovery,"DIAMANDIS, ELEFTHERIOS",MT SINAI HOSP-SAMUEL LUNENFELD RES INST,CANADA,"$264,033"
Ovarian Cancer,2011,NICHD,5R03HD058909-02,,Regulation of Fetal Ovarian Development by GATA4,"BOUMA, GERRIT",COLORADO STATE UNIVERSITY-FORT COLLINS,CO,"$70,560"
Ovarian Cancer,2011,NCI,5U01CA084955-12,,Atlantic Breast and Gynecologic Clinical Validation Center,"MARKS, JEFFREY",DUKE UNIVERSITY,NC,"$498,270"
Ovarian Cancer,2011,NCI,5U01CA151648-02,,RNA Nanotechnology in Cancer Therapy,"GUO, PEIXUAN",UNIVERSITY OF CINCINNATI,OH,"$435,815"
Ovarian Cancer,2011,NCI,5R01CA085566-07,,Psychological Intervention for Ovarian Cancer Patients,"MANNE, SHARON",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$519,524"
Ovarian Cancer,2011,OD,5R03CA141318-02,,Nuclear Pore Complex Architecture and Drug Resistance in Ovarian Carcinomas,"KOHTZ, DONALD",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$82,208"
Ovarian Cancer,2011,NCI,5R44CA125871-03,,Camptothecin Analogs for Cancer Therapy,"MORGAN, LEE","DEKK-TEC, INC.",LA,"$392,344"
Ovarian Cancer,2011,NCI,5R01CA122443-05,,Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology,"GOODE, ELLEN",MAYO CLINIC,MN,"$474,657"
Ovarian Cancer,2011,NICHD,5K12HD055881-05,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$50,000"
Ovarian Cancer,2011,OD,5K12HD055881-05,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$446,801"
Ovarian Cancer,2011,NCI,5F32CA144389-02,,"Transcription, Choice and the 3D Architecture of the Inactive X-Chromosome","MUGFORD, JOSHUA",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$51,326"
Ovarian Cancer,2011,NCI,5K22CA138563-02,,Obesity in ovarian cancer prognosis,"BANDERA, ELISA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$201,060"
Ovarian Cancer,2011,NICHD,5K99HD059985-02,,GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer,"WANG, CHENG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$90,000"
Ovarian Cancer,2011,NCI,5U01CA151461-02,,Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer,"O'HALLORAN, THOMAS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$433,830"
Ovarian Cancer,2011,NCI,5R44CA140047-03,,Cancer Progeniyor Cell Markers,"CHEN, WEN-TIEN","VITATEX, INC.",NY,"$703,024"
Ovarian Cancer,2011,NCI,5R43CA144591-02,,EGFR-Targeted Nanoemulsions for Imaging and Therapy of Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$152,606"
Ovarian Cancer,2011,NCI,5R01CA127562-05,,Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer,"UENO, NAOTO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$283,822"
Ovarian Cancer,2011,NCI,5R01CA149260-02,,Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy,"KUO, MACUS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2011,NCI,5R00CA133190-04,,Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer,"COWDEN DAHL, KAREN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$241,530"
Ovarian Cancer,2011,NCI,5R01CA151374-02,,Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients,"MARTIN, LAINIE",FOX CHASE CANCER CENTER,PA,"$345,304"
Ovarian Cancer,2011,NCI,5U01CA152990-02,,"Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery","SKATES, STEVEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$720,550"
Ovarian Cancer,2011,NIDDK,5R03DK090191-02,,THE ROLE OF CALCIUM SIGNALING ON PTEN REGULATION,"CHOW, YIP",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$76,725"
Ovarian Cancer,2011,NCI,1U24CA160036-01,,Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$1,962,728"
Ovarian Cancer,2011,NCI,1R01CA160541-01,,Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer,"TAINSKY, MICHAEL",WAYNE STATE UNIVERSITY,MI,"$315,400"
Ovarian Cancer,2011,NCI,1R33CA155618-01A1,,Array Microscope Assay for Cancer Cell Mechanics,"SUPERFINE, RICHARD",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$322,411"
Ovarian Cancer,2011,NCRR,1R21RR032333-01,,Development of Nanoproteomic Technologies,"LEE, CHENG",UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS,MD,"$187,500"
Ovarian Cancer,2011,NCI,1R01CA160998-01,,Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$418,641"
Ovarian Cancer,2011,NCI,1R21CA160917-01,,Role of the Fractalkine Signaling in EOC,"BARBOLINA, MARIA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$202,968"
Ovarian Cancer,2011,NCI,1R01CA154460-01A1,,CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$343,413"
Ovarian Cancer,2011,NCI,1R21CA161478-01,,Regulation of lipogenesis by lysophosphatidic acid in ovarian cancer,"FANG, XIANJUN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$162,581"
Ovarian Cancer,2011,NCI,1R15CA161970-01,,Development of aptamer-based detection and therapy strategies for ovarian cancer,"WHELAN, REBECCA",OBERLIN COLLEGE,OH,"$345,050"
Ovarian Cancer,2011,NIGMS,2R01GM032136-29,,Molecular Recognition of Proteins and Ligand Design,"JORGENSEN, WILLIAM",YALE UNIVERSITY,CT,"$353,873"
Ovarian Cancer,2011,RMAP,1R21NS075702-01,,Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$156,000"
Ovarian Cancer,2011,NCI,2R01CA075334-14,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$102,771"
Ovarian Cancer,2011,NCI,2R01CA112240-06A1,,The role of Fas as tumor promoter,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$294,148"
Ovarian Cancer,2011,NCI,1R01CA151570-01A1,,Co-registered photoacoustic and ultrasound  imaging  for non-invasive ovarian can,"ZHU, QUING",UNIVERSITY OF CONNECTICUT STORRS,CT,"$337,787"
Ovarian Cancer,2011,NCCAM,1R01AT005295-01A2,,Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$363,750"
Ovarian Cancer,2011,NCI,1R21CA156224-01A1,,Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$348,000"
Ovarian Cancer,2011,NCI,1R03CA162103-01,,Bilateral oophorectomy and cancer risk and mortality in African American women,"BOGGS, DEBORAH",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$61,516"
Ovarian Cancer,2011,NCI,4R01CA131582-03,,Identification of ovarian cancer plasma biomarkers,"SPEICHER, DAVID",WISTAR INSTITUTE,PA,"$413,376"
Ovarian Cancer,2011,NCI,4R01CA135354-03,,ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$306,953"
Ovarian Cancer,2011,NCI,4R01CA060731-17,,AFAP-110 as a cSrc activator in breast cancer,"FLYNN, DANIEL",COMMONWEALTH MEDICAL COLLEGE,PA,"$229,005"
Ovarian Cancer,2011,NCI,1R01CA158318-01A1,,mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$330,396"
Ovarian Cancer,2011,NCI,3R01CA047135-22S1,,Discovery of novel cytotoxic natural products from marine sponges and fungi,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$83,325"
Ovarian Cancer,2011,NCI,1R03CA162511-01,,Fish oil for the prevention and treatment of ovarian cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$72,750"
Ovarian Cancer,2011,NCI,1R13CA162868-01,,Symposium on Hereditary Breast and Ovarian Cancers: Lessening the Burde,"MUGGIA, FRANCO",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$5,000"
Ovarian Cancer,2011,NHGRI,1R21HG006415-01,,Genetic Education to Promote Counseling Attendance after Surgical Treatment (GET,"VADAPARAMPIL, SUSAN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$250,500"
Ovarian Cancer,2011,NCI,1R03CA157212-01A1,,Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers,"BUCHANAN, ADAM",DUKE UNIVERSITY,NC,"$84,838"
Ovarian Cancer,2011,NCI,5P30CA016042-36,5647,Women's Cancers,"GLASPY, JOHN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$54,704"
Ovarian Cancer,2011,NCI,5P01CA070970-13,0006,Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$311,009"
Ovarian Cancer,2011,NCI,5P30CA077598-13,5757,Women's Cancer,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$42,451"
Ovarian Cancer,2011,NCI,3R01CA086984-12S1,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$60,176"
Ovarian Cancer,2011,NCI,7R01CA129927-04,,Discovery of Gene Expression Signatures in Cancer Stroma,"WEST, ROBERT",STANFORD UNIVERSITY,CA,"$377,216"
Ovarian Cancer,2011,RMAP,3DP2OD007391-01S1,,ULTRASENSITIVE NANOLASERS FOR EPIGENETICS INVESTIGATIONS,"ARMANI, ANDREA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$169,614"
Ovarian Cancer,2011,NCI,4R44CA144586-02,,IHC Test for BRCA1 Hereditary Ovarian Cancer,"HOLT, JEFFREY","TISSUE GENETICS, INC.",CO,"$399,246"
Ovarian Cancer,2011,NCI,261200800001E-38-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","SAIC-FREDERICK, INC.",MD,"$1,978,965"
Ovarian Cancer,2011,NCI,3R01CA115483-07S1,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$58,992"
Ovarian Cancer,2011,NCI,3R01CA115780-06S1,,Diagnosis of Ovarian Cancer by Confocal Microendoscopy,"GMITRO, ARTHUR",UNIVERSITY OF ARIZONA,AZ,"$55,415"
Ovarian Cancer,2011,NCI,5P01CA087969-12,7547,Ovarian Cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$167,104"
Ovarian Cancer,2011,NCI,5P01CA087969-12,7548,Statistical Methods,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$115,209"
Ovarian Cancer,2011,NCI,5P01CA087969-12,7551,Biologic Specimen Management Core,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$474,112"
Ovarian Cancer,2011,NCI,1F31CA165853-01,,Therapeutic Targeting of Novel Antifolates to Solid Tumors via Folate Receptor,"MITCHELL, SHERMAINE",WAYNE STATE UNIVERSITY,MI,"$36,589"
Ovarian Cancer,2011,NCI,5U19CA148112-02,8865,Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI),"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$523,791"
Ovarian Cancer,2011,NCI,5U19CA148112-02,8866,"Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)","SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$862,070"
Ovarian Cancer,2011,NCI,5U19CA148112-02,8867,Functional assessment of genes and common genetic risk variants in ovarian cancer,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$599,443"
Ovarian Cancer,2011,NCI,5U19CA148112-02,8868,Genetic and environmental interaction analyses and risk prediction modeling,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$493,574"
Ovarian Cancer,2011,NCI,5P30CA014236-37,6412,Breast and Ovarian Oncology,"BERCHUCK, ANDREW",DUKE UNIVERSITY,NC,"$27,123"
Ovarian Cancer,2011,NCI,5P50CA083638-13,7949,Gene Methylation Signatures for Predictive Classification of Response to Therapy,"CAIRNS, PAUL",FOX CHASE CANCER CENTER,PA,"$289,614"
Ovarian Cancer,2011,NCI,5P50CA083638-13,7950,Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C,"DALY, MARY",FOX CHASE CANCER CENTER,PA,"$418,057"
Ovarian Cancer,2011,NCI,5P50CA083638-13,7951,Therapeutic Micro RNA Strategies for Ovarian Cancer,"HAMILTON, THOMAS",FOX CHASE CANCER CENTER,PA,"$496,164"
Ovarian Cancer,2011,NCI,5P50CA083638-13,7952,Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O,"GODWIN, ANDREW",FOX CHASE CANCER CENTER,PA,"$323,787"
Ovarian Cancer,2011,NCI,5P50CA083638-13,7955,Advancing T cell Therapy for Ovarian Cancer,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$516,260"
Ovarian Cancer,2011,NCI,5P50CA083638-13,7956,Administrative Core,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$141,118"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7923,Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer,"KAUFMANN, SCOTT",MAYO CLINIC,MN,"$331,189"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7924,Mechanisms of Immune Suppression in Ovarian Cancer,"KNUTSON, KEITH",MAYO CLINIC,MN,"$264,989"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7925,Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer,"GALANIS, EVANTHIA",MAYO CLINIC,MN,"$344,948"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7926,Flavopiridol Reverses Platinum Resistance in Ovarian Cancer,"BIBLE, KEITH",MAYO CLINIC,MN,"$233,601"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7927,Administration Core,"HARTMANN, LYNN",MAYO CLINIC,MN,"$231,078"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7928,Biospecimens/Patient Registry Core,"BELL, DEBRA",MAYO CLINIC,MN,"$197,529"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7929,Biostatistics Core,"OBERG, ANN",MAYO CLINIC,MN,"$207,250"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7930,Animal Models,"KNUTSON, KEITH",MAYO CLINIC,MN,"$178,889"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7931,Developmental Research Program,"KAUFMANN, SCOTT",MAYO CLINIC,MN,"$130,351"
Ovarian Cancer,2011,NCI,5P50CA136393-03,7932,Career Development Program,"COUCH, FERGUS",MAYO CLINIC,MN,"$65,176"
Ovarian Cancer,2011,NCI,5U54CA151662-02,8769,Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer,"GERNGROSS, TILLMAN",DARTMOUTH COLLEGE,NH,"$1,056,029"
Ovarian Cancer,2011,NCI,5U54CA151662-02,8772,Magnetic nanoparticle Immunotherapy against Ovarian Cancer,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$236,995"
Ovarian Cancer,2011,NCI,5U54CA151662-02,8775,"Toxicology, Pathology and Biodistribution Core (TPB Core)","LEWIS, LIONEL",DARTMOUTH COLLEGE,NH,"$92,723"
Ovarian Cancer,2011,NCI,261200900010C-3-0-1,,BIOMEDICAL (MANAGEMENT/SUPPORT),"MADHAVEN, SUBHA",GEORGETOWN UNIVERSITY,DC,"$1,200,000"
Ovarian Cancer,2011,NIGMS,3R01GM088055-12S1,,Structural and Functional Characterization of BRCA1/BARD1,"KLEVIT, RACHEL",UNIVERSITY OF WASHINGTON,WA,"$115,500"
Ovarian Cancer,2011,NIAID,5P01AI068730-05,0005,COMPLEMENT IN CANCER ESTABLISHMENT AND GROWTH,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$284,730"
Ovarian Cancer,2011,NCI,5U54CA151884-02,5023,Nanoformulations for siRNA Delivery to Ovarian Cancer,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$260,940"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7964,Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$114,878"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7965,Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V,"DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$257,611"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7966,MicroRNA Signature of Poorly Resectable Ovarian Cancer,"TEWARI, MUNEESH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$200,810"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7967,Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$257,007"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7968,Vaccinating against IGFBP-2 to prevent ovarian cancer relapse,"DISIS, MARY",UNIVERSITY OF WASHINGTON,WA,"$437,712"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7969,Leadership and Administration Core,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$139,711"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7970,Clinical Specimen Management and Characterization Core,"KNUDSEN, BEATRICE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$263,687"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7971,"Participant Recruitment, Enrollment and Characterization Core","DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$230,576"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7972,Biostatistics and Informatics Core,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$158,052"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7973,Developmental Research Program,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$62,478"
Ovarian Cancer,2011,NCI,5P50CA083636-13,7974,Career and Mentoring Development Program,"COLLINS, STEVEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$62,478"
Ovarian Cancer,2011,NCI,5U54CA151459-02,8855,Next Generation Smart Nanoparticles,"ALIVISATOS, PAUL",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$999,338"
Ovarian Cancer,2011,NCI,5U54CA151459-02,8856,Magneto-Nano Diagnostic and Analytical Devices for Cancer,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$266,897"
Ovarian Cancer,2011,NCI,5U54CA151459-02,8858,Integration of Nano-Molecular Imaging and Nanosensors,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$182,401"
Ovarian Cancer,2011,NCI,5U54CA151459-02,8865,Pilot Projects,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$58,394"
Ovarian Cancer,2011,NCI,3R01CA133117-03S1,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$29,014"
Ovarian Cancer,2011,NCI,3U10CA027469-31S1,,Gynecologic Oncology Group,"DISAIA, PHILIP",GYNECOLOGIC ONCOLOGY GROUP,MD,"$719,110"
Ovarian Cancer,2011,NCI,3R15CA151006-01S1,,Modulation of RGS proteins and Ovarian Cancer Chemoresistance,"MURPH, MANDI",UNIVERSITY OF GEORGIA (UGA),GA,"$34,526"
Ovarian Cancer,2011,NCI,5U54CA151668-02,8844,Multistage Vectors (MSV) for Ovarian Cancer Therapeutics,"LOPEZ-BERESTEIN, GABRIEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$674,633"
Ovarian Cancer,2011,NCI,5U54CA151668-02,8845,Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,795"
Ovarian Cancer,2011,NCI,5U54CA151668-02,8847,Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri,"ARAP, WADIH",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$288,000"
Ovarian Cancer,2011,NCI,5U54CA151819-02,8878,"Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an","HOOD, LEROY",INSTITUTE FOR SYSTEMS BIOLOGY,WA,"$695,840"
Ovarian Cancer,2011,NCI,5U54CA151819-02,8879,Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy,"RADU, CAIUS",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$366,024"
Ovarian Cancer,2011,NCI,5U54CA151819-02,8883,Administrative Core,"HEATH, JAMES",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$111,474"
Ovarian Cancer,2011,NCI,5P30CA118100-07,6320,Womens Cancers Research Program,"PROSSNITZ, ERIC",UNIVERSITY OF NEW MEXICO,NM,"$47,022"
Ovarian Cancer,2011,NCI,5U54CA151881-02,5122,Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA,"TORCHILIN, VLADIMIR",NORTHEASTERN UNIVERSITY,MA,"$782,480"
Ovarian Cancer,2011,NCI,5U54CA151881-02,5124,Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance,"MINKO, TAMARA",RUTGERS THE STATE UNIVERSITY OF NJ,NJ,"$267,117"
Ovarian Cancer,2011,NCI,N02CN63300-7-0-4,,Computer Support for Ovarian Cancer Screening in PLCO Cancer Screening Trials,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$429,776"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7762,P1 - Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$832,573"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7764,P2 - Targeting DII4-Notch Signaling in Ovarian Cancer,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$195,270"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7767,P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$196,319"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7768,P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$175,173"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7770,P5 - Gene-modified MSCs for Controlling Ovarian Cancer,"MARINI, FRANK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$176,118"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7771,Administrative Core,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$24,657"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7772,"Biostatistics, Bioinformatics and Systems Biology (BBSB) Core","ATKINSON, E",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$270,833"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7773,Pathology Core,"BROADDUS, RUSSELL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$114,893"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7774,Developmental Research Program,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$79,253"
Ovarian Cancer,2011,NCI,5P50CA083639-12,7775,Career Developmental Program,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$52,836"
Ovarian Cancer,2011,NCI,N1CN25516A-100-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","STEINMETZ, KAREN",NIH,,"$277,681"
Ovarian Cancer,2011,NCI,N1CN75022A-68-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$743,860"
Ovarian Cancer,2011,NCI,2P30CA006927-48,8440,Histopathology,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$65,097"
Ovarian Cancer,2011,NIA,1ZIAAG000395-04,,Expression and roles of claudin-3 and claudin-4 in ovarian cancer,"MORIN, PATRICE",NIH,,"$833,790"
Ovarian Cancer,2011,NIA,1ZIAAG000396-04,,Mechanisms of drug resistance in ovarian cancer,"MORIN, PATRICE",NIH,,"$230,011"
Ovarian Cancer,2011,NIA,1ZIAAG000397-04,,Claudin-7 in ovarian cancer,"MORIN, PATRICE",NIH,,"$287,514"
Ovarian Cancer,2011,NIA,1ZIAAG000398-04,,Expression and roles of microRNAs in ovarian tumorigenesis,"MORIN, PATRICE",NIH,,"$575,027"
Ovarian Cancer,2011,NIEHS,1ZIAES049032-15,,Environmental Exposure and DNA Damage,"TAYLOR, JACK",NIH,,"$1,209,937"
Ovarian Cancer,2011,NCI,N1CN25476A-85-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",MD,"$3,907,852"
Ovarian Cancer,2011,NCI,5U54CA113001-07,8572,Interrogating Epigenetic Changes in Cancer Genomes,"HUANG, TIM",OHIO STATE UNIVERSITY,OH,"$1,728,938"
Ovarian Cancer,2011,NCI,1ZIABC006161-28,,DNA Topoisomerases as Target of Action of Anticancer Drugs,"POMMIER, YVES",NIH,,"$1,132,850"
Ovarian Cancer,2011,NCI,1ZIABC010030-16,,Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,"AMBUDKAR, SURESH",NIH,,"$1,204,831"
Ovarian Cancer,2011,NCI,1ZIABC010038-16,,Molecular Cytogenetics of Solid Tumors,"POPESCU, NICOLAE",NIH,,"$1,078,567"
Ovarian Cancer,2011,NCI,1ZIABC010549-09,,Zebrafish Models of Cancer,"HICKSTEIN, DENNIS",NIH,,"$747,679"
Ovarian Cancer,2011,NCI,1ZIABC010830-05,,Mechanisms of non-classical multidrug resistance in cancer,"GOTTESMAN, MICHAEL",NIH,,"$741,838"
Ovarian Cancer,2011,NCI,1ZIABC010891-04,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$747,016"
Ovarian Cancer,2011,NCI,1ZIABC010935-04,,Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,"STRACKE, MARY",NIH,,"$237,348"
Ovarian Cancer,2011,NCI,1ZIABC011054-04,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$651,396"
Ovarian Cancer,2011,NCI,1ZIABC011188-03,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$919,966"
Ovarian Cancer,2011,NCI,1ZIABC011197-03,,Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,"APPELLA, ETTORE",NIH,,"$436,895"
Ovarian Cancer,2011,NCI,1ZIABC011311-02,,Identification of genetic interactors of Brca2,"SHARAN, SHYAM",NIH,,"$359,613"
Ovarian Cancer,2011,NCI,1ZIABC011315-02,,Molecular characterization of endometrial cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$186,113"
Ovarian Cancer,2011,NCI,1ZIABC011353-02,,Development and validation of preclinical mouse model for serous ovarian cancer,"VAN DYKE, TERRY",NIH,,"$1,449,087"
Ovarian Cancer,2011,NCI,1ZIACP010126-16,,Hormone-Related Cancers,"BRINTON, LOUISE",NIH,,"$2,752,919"
Ovarian Cancer,2011,NCI,1ZIACP010128-16,,Therapeutic and Diagnostic Factors as Related to Cancer Risk,"BRINTON, LOUISE",NIH,,"$1,446,670"
Ovarian Cancer,2011,NCI,1ZIACP010144-13,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"GREENE, MARK",NIH,,"$3,997,558"
Ovarian Cancer,2011,NCI,1ZIACP010145-12,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"GREENE, MARK",NIH,,"$1,800,935"
Ovarian Cancer,2011,NCI,1ZIACP010152-12,,PLCO Trial Etiologic and Early Marker Study,"HSING, ANN",NIH,,"$2,293,962"
Ovarian Cancer,2011,NCI,1ZIACP010187-07,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$808,923"
Ovarian Cancer,2011,NCI,1ZIACP010188-07,,Risk prediction methods,"GAIL, MITCHELL",NIH,,"$642,941"
Ovarian Cancer,2011,NCI,1ZIACP010207-02,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$1,359,323"
Ovarian Cancer,2011,NHGRI,1ZIAHG000120-15,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$86,010"
Ovarian Cancer,2011,NHGRI,1ZIAHG200323-07,,Genomic and Functional Analyses of Regulatory Regions in Vertebrate Sequences,"ELNITSKI, LAURA",NIH,,"$1,099,433"
Ovarian Cancer,2011,NCI,1ZIASC006353-29,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$1,099,106"
Ovarian Cancer,2011,NCI,1ZIASC007263-19,,TRAIL-induced Cell Death in Breast Cancer Cells,"LIPKOWITZ, STANLEY",NIH,,"$377,005"
Ovarian Cancer,2011,NCI,1ZIASC009163-24,,Signal Transduction Therapy--Basic Science,"KOHN, ELISE",NIH,,"$378,296"
Ovarian Cancer,2011,NCI,1ZIASC009374-20,,Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,"KOHN, ELISE",NIH,,"$252,198"
Ovarian Cancer,2011,NCI,1ZIASC009375-19,,Signal Transduction Therapy--Clinical,"KOHN, ELISE",NIH,,"$435,614"
Ovarian Cancer,2011,NCI,1ZICBC010930-04,,Molecular Cytogenetics Core,"ROSCHKE, ANNA",NIH,,"$413,917"
Ovarian Cancer,2011,NCI,1ZIEBC011136-03,,The CCRWalter Reed Army Medical Center Gynecologic Cancer Program Research Lab,"KOHN, ELISE",NIH,,"$80,245"
Ovarian Cancer,2011,NCI,1ZIHBC010470-09,,Bioinformatic Tools in Cancer Research,"BUETOW, KENNETH",NIH,,"$754,625"
Ovarian Cancer,2011,NCI,261201100091C-0-0-1,,TAS::75 0849::TAS TOPIC 255 SELECTIVE AND POTENT INHIBITORS OF TUMOR SPECIFIC GL,"PEARSON, PAUL",RUGA CORPORATION,CA,"$183,071"
Ovarian Cancer,2011,NCRR,5M01RR000188-47,6609,THE MOLECULAR BASIS OF FAMILIAL CANCER PREDISPOSITION SYNDROMES,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$1,583"
Ovarian Cancer,2011,NCRR,5G12RR003032-27,6851,BL3 AND FLOW CYTOMETRY CORE,"LIU, BINDONG",MEHARRY MEDICAL COLLEGE,TN,"$157,239"
Ovarian Cancer,2011,NCRR,5P51RR000163-52,7441,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$56,997"
Ovarian Cancer,2011,NIA,5P51RR000163-52,7441,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,242"
Ovarian Cancer,2011,NCRR,5P51RR000163-52,7450,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$42,716"
Ovarian Cancer,2011,NIA,5P51RR000163-52,7450,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,$931
Ovarian Cancer,2011,NCRR,5P20RR016477-11,8501,"PI3K, AKT AND ERR-ALPHA PATHWAYS IN FLAVONOID-INHIBITING TUMORIGENESIS","CHEN, ALLAN",MARSHALL UNIVERSITY,WV,"$144,326"
Ovarian Cancer,2011,NCRR,5P20RR016479-11,5067,AN INVESTIGATION OF IMMUNE CELL INTERACTIONS WITH CANCER,"GUBBELS, JENNIFER",UNIVERSITY OF SOUTH DAKOTA,SD,"$34,615"
Ovarian Cancer,2011,NCRR,5P41RR002250-26,5264,OVARIAN CANCER PLATELETS,"SOOD, ANIL",BAYLOR COLLEGE OF MEDICINE,TX,"$36,793"
Ovarian Cancer,2011,NCRR,5P41RR000954-34,5594,GROUP VIA PHOSPHOLIPASE A2 IN BOTH HOST AND TUMOR CELLS IS INVOLVED IN OVARIAN,"XU, YAN",WASHINGTON UNIVERSITY,MO,"$4,042"
Ovarian Cancer,2011,NCRR,5P41RR013461-13,6884,FEASIBILITY OF NANOPARTICLE-MEDIATED PACLITAXEL DELIVERY,"LAM, KIT",UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB,CA,"$46,810"
Ovarian Cancer,2011,NCRR,5P41RR008079-19,6975,MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY OF THE OVARIES AT 3 TESLA,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$30,257"
